1228839-23-3 Usage
General Description
"[1,1'-Biphenyl]-4-carboxylic acid, 2'-[(1R)-1-[(2R)-3-[[2-[3-fluoro-4-(methylthio)phenyl]-1,1-dimethylethyl]amino]-2-hydroxypropoxy]ethyl]-3-methyl-" is a chemical compound with a complex and lengthy name. It contains a biphenyl carboxylic acid group and a substituted 2'-[(1R)-1-[(2R)-3-[[2-[3-fluoro-4-(methylthio)phenyl]-1,1-dimethylethyl]amino]-2-hydroxypropoxy]ethyl]-3-methyl group. The compound has potential applications in medicinal chemistry, particularly in the development of pharmaceuticals and drug research. Its structure suggests that it may have biological activity and could be a significant molecule in drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 1228839-23-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,8,8,3 and 9 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1228839-23:
(9*1)+(8*2)+(7*2)+(6*8)+(5*8)+(4*3)+(3*9)+(2*2)+(1*3)=173
173 % 10 = 3
So 1228839-23-3 is a valid CAS Registry Number.
1228839-23-3Relevant articles and documents
1,1-(Dimethyl-Ethylamino)-2-Hydroxy-Propoxy]-Ethyl}-3-Methyl-Biphenyl-4- Carboxylic Acid Derivatives As Calcium Receptor Antagonists
-
Page/Page column 60, (2010/10/03)
The present invention is directed to novel 1,1 -(dimethyl-ethylamino)-2- hydroxy-propoxy]-ethyl}-3-methyl-biphenyl-4-carboxylic acid derivatives and pharmaceutically acceptable salts thereof of structural formula I wherein the variable R1 is as described herein. Also provided are pharmaceutical compositions comprising the compounds of formula I as well as methods of treatment employing compounds of formula I to treat a disease or disorder characterized by abnormal bone or mineral homeostasis such as hypoparathyroidism, osteoporosis, osteopenia, periodontal disease, Paget's disease, bone fracture, osteoarthritis, rheumatoid arthritis, and humoral hypercalcemia of malignancy.